Leaflet STRESAM 50mg capsules


Indicated for: anxiety

Route of administration: oral

Substance: etifoxin (anxiolytic)

ATC: N05BX03 (Nervous system | Anxiolytics | Other anxiolytics)

Etifoxine is an anxiolytic medication used to reduce anxiety and psychological tension. It acts on the central nervous system, providing a calming and relaxing effect without causing dependence like other classic anxiolytics.

Etifoxine is administered orally as capsules, according to the doctor's instructions. The dose and duration of treatment are determined individually, depending on the severity of symptoms and the patient's response to therapy.

Side effects may include drowsiness, dizziness, digestive disorders, or, rarely, allergic reactions. It is important that the treatment is followed under medical supervision, especially in people with liver conditions or those taking other medications.

Etifoxine is an effective option for managing anxiety, offering a good safety profile and a low risk of dependence, but its use should be done with caution and under medical monitoring.

General data about STRESAM 50mg

  • Substance: etifoxin
  • Date of last drug list: 01-03-2022
  • Commercial code: W58407001
  • Concentration: 50mg
  • Pharmaceutical form: capsules
  • Quantity: 24
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: BIOCODEX - FRANTA
  • Holder: BIOCODEX - FRANTA
  • Number: 10139/2017/01
  • Shelf life: 3 years